ReviewPharmaceutics2021

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention.

Nazanin Momeni Roudsari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.